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Background: New York City (NYC) is currently home to the largest Bangladeshi population in the United States
(US) at approximately 62,000 individuals. The high prevalence of Type 2 diabetes mellitus (T2DM) among
Bangladeshis has been well documented in Bangladesh, as well as in Canada and the United Kingdom (UK).
However, little is known about the diabetes prevalence and management practices of US Bangladeshis. This paper
describes the protocol for a Community Health Worker (CHW) intervention to improve diabetic management and
control among Bangladeshis with diabetes in NYC.
Methods/Design: For a two-arm, randomized controlled trial (RCT), investigators will recruit a sample of 256
participants, all of whom are 1) of Bangladeshi descent, 2) residing in NYC, 3) diagnosed with T2DM and a recent
Hemoglobin A1c (HbA1c) of ≥ 6.5, and 4) between the ages of 21–85. The treatment group receives a six-month
CHW-led intervention consisting of five monthly group educational sessions, two one-on-one visits, and follow-up
phone calls as needed from a CHW. The control group receives an introductory educational session only. Primary
and secondary outcomes include clinical and behavioral measures, such as HbA1c and weight change, access to
and utilization of care (i.e. appointment keeping and use of specialty care), and knowledge and practice of physical
activity and healthful eating. Additionally, information regarding CHW characteristics, the processes and mechanisms
for influencing healthful behavior change, and fidelity of the intervention are collected. Outcomes are measured at
Baseline, 3-Months, 6-Months for both groups, and at 12-Months for the treatment group.
Discussion: To our knowledge, this study represents the first attempt to document the efficacy of T2DM
management strategies in the NYC Bangladeshi population. Thus, future qualitative and quantitative findings of the
submitted protocol will fill an important gap in the health disparities literature.
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New York City (NYC) is currently home to the largest
Bangladeshi population in the United States (US). From
2000 to 2010, the Bangladeshi population in NYC expe-
rienced a 119% increase in size, growing from 28,269 to
61,788 individuals [1]. In contrast, the Asian American
community in NYC overall increased by 30%. The addition
of approximately 33,000 Bangladeshis to the city’s diverse
cultural landscape represented the second-largest numer-
ical increase among Asian groups in the city in the last
decade. World Health Organization (WHO) estimates
placed Bangladesh on the top ten list of countries with the
highest number of estimated cases of Type 2 diabetes
mellitus (T2DM) prevalence in 2000 [2]. WHO projections
for 2030 estimate the prevalence of T2DM in Bangladesh
to increase to over 11 million. Although the prevalence of
T2DM among Bangladeshis has been well documented in
the home country [2-5], as well as in Canada and the U.K
[6,7], little is known about its prevalence and management
practices among US Bangladeshis. Studies conducted
among South Asian populations (which include individuals
from India, Pakistan, and Bangladesh) in the US have
found that these groups are 4 to 7 times more likely
to suffer from T2DM than the general population
[8-10]. Several community-based samples of Bangladeshis
in NYC report diabetes prevalence rates in the range
of 17-25%, as compared to 10% in non-Hispanic
whites [10-12].
In addition to being disproportionally at risk for dia-
betes, Bangladeshis in NYC have a unique demographic
profile that may impact access to and utilization of care,
resulting in poorer health outcomes. According to the
US Census, 53% of Bangladeshis in NYC speak English
less than “very well” and approximately 33% live below the
poverty line (compared to the citywide average of 19%)
[1]. The above demographic factors, coupled with an
increased risk profile for diabetes, highlight the need
for culturally- and linguistically-relevant interventions
in this community. Community Health Workers (CHWs)
have been suggested as a culturally-based strategy to ad-
dress this need among other ethnic and immigrant popu-
lations. CHWs are generally indigenous to the community
in which they work – ethnically, linguistically, socioeco-
nomically, and experientially – providing them with a
unique understanding of the norms, attitudes, values, and
strengths of community members [13,14]. This under-
standing is incredibly valuable given the growth of minor-
ity and underserved populations whom health care
providers have difficulty reaching or communicating with
[15,16]. Moreover, given that the nature of chronic disease
requires long-term management and life-style modifica-
tion, the use of CHWs is increasingly being viewed as a
low-cost approach to improving community health and
well-being, reducing health disparities, and bridging thecultural and social barriers between underserved commu-
nities and the health care system [14,17].
While there has been formative work to study the role
of health beliefs, behaviors, and barriers to/facilitators of
T2DM management in this community [18,19], no known
studies to date have tested the efficacy of a CHW inter-
vention in the Bangladeshi community. We present the
protocol of a research study designed to fill this gap in
knowledge. The DREAM (Diabetes Research, Action, and
Education for Minorities) Project is a 6-month random-
ized controlled trial (RCT) that utilizes the CHW model
to improve diabetic control and management among
Bangladeshis living in NYC.Methods/Design
Objectives
The primary aim of the current study is to assess the effi-
cacy of a CHW intervention to improve management and
control among Bangladeshis with T2DM in NYC. Second-
ary aims include examining the intervention’s effect on
diabetes knowledge, self-management practices, health be-
haviors, and access to primary and specialty care services
among study participants.Ethics approval
The study protocol and procedures were approved by the
Institutional Review Board at the New York University
School of Medicine on July 6, 2009. Written informed
consent is obtained from study participants by trained
CHWs or study personnel prior to enrollment.Sample size calculations
The size of the study population is based on the primary
outcome measure of HbA1c and was estimated by using
previous changes observed in a pilot study as well as in
previous research [19,20]. Control group HbA1c esti-
mates were based on hospital patients receiving usual
care. An absolute difference of 0.5% in HbA1c between
the groups (6.7 vs. 6.2) with a power of 0.8 and signifi-
cance level of 0.05 may be detected with a total of 40 in-
dividuals in each group, and an absolute difference of
0.3% in HbA1c between the groups (6.7 vs. 6.4) with a
power of 0.8 and significance level of 0.05 may be de-
tected with a total of 120 individuals in each group. The
sample size calculation was based on a medium effect
size of the primary outcomes between the intervention
and control group. Approximately 256 enrolled study
participants were randomized each to the treatment and
control groups. We anticipated that 75% of study partic-
ipants would be followed to completion of the study at
6 months (n = 96 in each group).
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The study population of interest is Bangladeshi individuals
residing in NYC that have been diagnosed with T2DM.
Study eligibility includes the following:
(a)confirmed clinical diagnosis of T2DM with a
Hemoglobin A1c (HbA1c) of ≥ 6.5%; and
(b) male or female between the ages of 21–85 years old;
and
(c)willingness to be randomized to either treatment or
control groups.
Participants are ineligible for enrollment in the study
if s/he:
(a) is or was on renal dialysis; or
(b) is experiencing an acute or terminal illness or
serious mental illness; or
(c) had a history of recent coronary event within the
last 3 months of recruitment; or
(d) is pregnant at the time of recruitment; or
(e) experienced other severe medical conditions that
might preclude participation; or
(f ) has poor short-term prognosis (expected death
in <2 years); or
(g) is participating in another research study.
Study design
Aggregated patient registry data from a large, public
hospital in NYC was used to gauge the approximate size
of the community served at this particular healthcare
institution. A targeted enrollment of n = 256 was used
for this study as previously described in the power calcu-
lation. The projected sample size also takes into account
previous literature detailing refusal and attrition rates
for peer- and CHW-led health interventions [21-23].
The study is a two-arm RCT design. Following screen-
ing, consenting, and study enrollment, participants are
randomly assigned to either treatment or control group
by a blinded study staff member using IBM SPSS Statis-
tics, Version 19.0 (IBM Corp). Study groups are strati-
fied by gender and age. Both study staff and participants
are notified of subject randomization allocation. Add-
itionally, all participants randomized to the control
groups are offered the opportunity to receive the full
intervention after serving as a control for the 6-month
study period. This strategy is part of a multi-pronged ef-
fort to improve data collection rates among participants
randomized to the control group, as well as an effort to
conduct the study in alignment with the principles of
community-based participatory research (CBPR) and in
response to community concerns regarding the ethics
of withholding potentially beneficial interventions for
community members.Study recruitment
We drew upon literature which suggested that a multi-
pronged recruitment approach that considers cultural and
contextual factors impacting participation in research
should be applied [24-27]. One strategy employed includes
the use of a mass mailing and phone-follow-up to poten-
tial participants recruited from a public hospital in NYC
that serves a large Bangladeshi patient population. Patients
are sent introductory letters describing the study and
providing promotional materials, both of which were in
Bengali and English. Patients then receive a follow-up
phone call from a CHW approximately two weeks later,
at which time additional study information is provided
and eligibility information is obtained via a standardized
script and screening questionnaire. The screening tool in-
cludes questions related to the protocol-specified inclusion/
exclusion criteria, as well as questions regarding planned
travel to the home country, which was identified as a
significant barrier to retention during the formative
phase of this study [18]. The above recruitment proto-
col has also been previously used in several diabetes and
lifestyle interventions primarily targeting Caucasian and
Hispanic participants [28,29]. Figure 1 illustrates the flow
of recruitment and enrollment using this approach.
In addition to the mailing and phone follow-up, screen-
ing and tabling events are also held in the hospital atrium
2–3 times per week during the recruitment periods.
CHWs provide study recruitment materials in Bengali to
interested study participants who are passing to and from
clinic appointments, and screen those interested in partici-
pation. During these encounters with potential partici-
pants, contact information is also obtained, so that CHWs
can complete additional follow-up and continue to build
rapport with interested participants prior to obtaining
informed consent for participation in the intervention.
Figure 2 illustrates the flow of recruitment and enroll-
ment using this approach.
Other recruitment methods employed include “snowball”
or word-of-mouth referrals, which are accepted from
screened and enrolled participants. The project staff also
works with local faith-based and community-based orga-
nizations to do outreach and screening events in neigh-
borhoods in close proximity to the hospital site. Lastly,
articles are placed in local Bangladeshi newspapers which
include information regarding the study and (in some
cases) contact information for study staff. These articles
are published with the intention of promoting general
awareness of the program among the community of inter-
est, and not as a direct recruitment tool.
CHW intervention
Individuals randomized to the treatment group receive a
multi-component intervention comprising of group edu-
cational sessions, one-on-one visits, and phone follow-up
Potential participant is sent a letter and program materials.
CHW(s) follows up with eligible participant via phone, explains the
study procedures, and if willing, participant is scheduled to
complete consent form, Screening questionnaire, and Baseline
Survey.
Treatment group participants are
invited to attend Sessions 2–5.
Control group invited to attend
intervention sessions 2-5 upon
initiation of a new cohort
Month 5
Second One-on-One Visit
Month 4,Session 4: Diabetes Complications 
12-month Survey
All participants invited to attend Session 1, Managing Diabetes.
Collect from all – BL Survey, A1C, lipids, clinical measurements.
Participants are randomized into Treatment and Control Groups.
Month 3, Session 3: Physical Activity
3-Mo Survey, Clinical Measurements
Month 2, Session 2: Nutrition
First One-on-One Visit
Month 6, Session 5: Stress Management
6-Mo Survey, Clinical Measurements
6-Mo Survey, Clinical Measurements
3-Mo Survey, Clinical Measurements
Figure 1 Recruitment process flowchart (Mass Mailing).
Islam et al. BMC Public Health 2014, 14:177 Page 4 of 9
http://www.biomedcentral.com/1471-2458/14/177by one of three full-time CHWs. Group educational
sessions occur once per month, for five months, and are
held in a community-based or hospital setting. Each
session is conducted in Bengali and involves a discus-
sion of different content areas related to T2DM, such as
nutrition, physical activity, and complications of dia-
betes. Educational sessions are guided by the Health
Belief Model [30] and Social Support Theory [31]. For
example, in describing diabetes, CHWs explain the
prevalence of T2DM and described risk factors. These
discussions are intended to make participants aware of
their risk and to enhance participants’ acceptance of their
diabetes diagnosis—i.e., altering participants’ perceivedsusceptibility to diabetes. Educational sessions are also sup-
plemented with materials/handouts that have been adapted
from standardized curriculums and translated for use in the
Bangladeshi community [19]. Materials are tailored with
specific cultural and religious practices in mind, with guid-
ance and input from both project CHWs and a community
coalition comprised of representatives from academic
institutions, healthcare agencies, and community-based
organizations [32]. Project staff and coalition also utilize
results from a mixed-methods formative research study
that were completed prior to study implementation with
the target community to help guide the process of tailoring
materials and curriculum content [18].
CHW(s) explains the study to eligible participant, and if willing, 
participant completes consent form and/or Screening 
questionnaire.  If participant does not have time, participant can 
leave contact info for additional f/u and invitation to first session.
Treatment group participants are 
invited to attend Sessions 2–5. 
Control group invited to attend
intervention sessions 2-5 upon
initiation of a new cohort
Month 5
Second One-on-One Visit
Month 4, Session 4: Diabetes Complications
12-month Survey
Participant eligibility is confirmed via MISYS EMR system. 
All participants invited to attend Session 1, Managing Diabetes.  
Collect from all – BL Survey, A1C, lipids, clinical measurements. 
Participants are randomized into Treatment and Control Groups.
Month 3, Session 3: Physical Activity
3-Mo Survey, Clinical Measurements
Month 2, Session 2: Nutrition
First One-on-One Visit
Month 6, Session 5: Stress Management
6-Mo Survey, Clinical Measurements
6-Mo Survey, Clinical Measurements
3-Mo Survey, Clinical Measurements
Potential participant presents at screening or tabling event.  
Figure 2 Recruitment process flowchart (Recruitment/Tabling Event).
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participants receive two one-on-one visits during the six
month study period. Each visit provides study partici-
pants with the opportunity to discuss individualized care
needs related to diabetic management with a CHW, as
well as to discuss goal-setting around health behaviors
using motivational interviewing techniques. CHWs also
help to provide referrals to specialty care (e.g. podiatry
and dentistry), as well as to social service or community-
based resources for needs related to housing, foodassistance, immigration, etc. Lastly, CHWs utilize phone
follow-up between educational sessions and one-on-one
visits to both encourage adherence to discussed care
plans, as well as to improve study retention and data
collection rates by minimizing study drop-out. All
of the above interactions with study participants are
documented in CHW progress notes and call logs to
ensure fidelity to study protocol as well as to capture
secondary study outcomes related to access to and
utilization of care.
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one-time, introductory educational session only. This ses-
sion focuses on general concepts regarding diabetes man-
agement, and is the same introductory session received by
the treatment group. Individuals randomized to the con-
trol group are instructed to seek medical care as usual
from their regular physician. Previous literature has under-
scored the importance of providing meaningful incentives
as a strategy to maximize retention in community-based
studies [33]. Accordingly, participants are provided round-
trip MetroCards® ($4.50 - $5 value) at each educational
session and at each data collection timepoint. Additionally,
treatment group participants are given a small incentive
related to the session topic (e.g. bag of brown rice, pill
box, pedometer, etc.) at each session, as well as a ticket
towards a $100 raffle drawing to be completed at the
end of the intervention period.
Data collection
Data collection occurs with treatment and control group
participants at Baseline, 3-Month, and 6-Month time-
points, with a +/− 30 day window. Additionally, theRecruitment / Scre
Study Enrollme
(Completion of Baseline Survey &
Randomization (n =
Treatment Group - 
Full CHW Intervention
(n = 128)
Intro
Follow-Up at 
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Figure 3 Overall study design flowchart.treatment group is contacted at the 12-Month timepoint
to obtain long-term follow-up information. Within the clin-
ical setting, providers collect Hemoglobin A1c (HbA1c)
levels and lipid profile according to the standard of
care lab schedule for management of each participant.
Outside of the clinical setting, questionnaire data and
several clinical endpoints (height, weight, blood pressure,
and waist/hip circumference) are obtained; all procedures
are completed in-language by CHWs or trained study
personnel. In addition to the above timepoints, question-
naire data is collected at each one-on-one visit pertaining
to access and utilization of primary and specialty care,
as well as barriers encountered in maintaining a healthy
diet, engaging in physical activity, and managing stressors.
Figure 3 demonstrates procedures for each study group
and overall flow of study design.
Study outcomes
Primary study outcomes include: (1) decreased levels of
HbA1c, lipid profiles, and systolic and diastolic blood
pressure and a greater proportion of individuals with con-
trolled blood pressure; (2) greater access and utilization ofening
nt 
 Clinical Measures)
Excluded - I/E Criteria
 256)
Control Group -
duction Session Only
(n = 128)
Follow-Up at 
MO and 6MO (n=96)
D
ropout / Lost to Follow
-Up
Analysis
(n=96)
Table 1 Measurement domains & data collection
timepoints
Component Baseline 3 MOS 6 MOS 12 MOS
Socio-demographic
(pre-disposing characteristics):
Sex, age, marital status, country
of birth, years in U.S., education,
household size, home language,
English fluency
✓
Employment Status ✓ ✓ ✓ ✓
Health insurance ✓
Barriers to healthcare ✓
Reinforcing characteristics:
Social support ✓ ✓ ✓ ✓
Self-efficacy ✓ ✓ ✓ ✓
Social capital ✓ ✓ ✓ ✓
Religiosity ✓ ✓ ✓ ✓
Knowledge and health
behaviors:
Diabetes knowledge ✓ ✓ ✓ ✓
Diabetes management ✓ ✓ ✓ ✓
Dietary practices ✓ ✓ ✓ ✓
Food behavior ✓ ✓ ✓ ✓
Tobacco use ✓ ✓ ✓ ✓
Physical activity ✓ ✓ ✓ ✓
Medication adherence ✓ ✓ ✓ ✓
Mental health ✓ ✓ ✓ ✓
Clinical measurements:
HbA1c ✓ ✓ ✓ ✓
Blood pressure ✓ ✓ ✓ ✓
Height ✓
Weight ✓ ✓ ✓ ✓
BMI ✓ ✓ ✓ ✓
Waist, Hip, Waist-to-Hip ratio ✓ ✓ ✓ ✓
Lipid profile ✓ ✓ ✓ ✓
Knowledge and acceptability
of CHWs
✓ ✓ ✓
Program evaluation
✓
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practice of physical activity and healthful eating. Sec-
ondary outcomes include: (1) increased levels of per-
ceived social support; (2) greater perceived benefits
and lower perceived barriers; and (3) higher levels of
self-efficacy.
Clinical measures included HbA1c, lipid profile (choles-
terol, HDL, LDL, and triglycerides), systolic and diastolic
blood pressure, height, and weight. BMI is calculated at
each timepoint using current weight and height recorded
at baseline. Waist-to-hip ratio is calculated using waist
and hip circumference measurements obtained at each
timepoint. Blood pressure is collected using previously
validated methods for community-based settings, given
that data collection frequently occurred outside of the
hospital [34]. Three resting blood pressure measure-
ments approximately 2–3 minutes apart are collected at
each timepoint using an OMRON HEM 711-AC auto-
matic blood pressure monitor with participants in a seated
position. The average of the second and third blood
pressure readings is recorded as the final value. HbA1c
and lipid profile were measured through a laboratory
blood test.
Predisposing & reinforcing characteristics
Information on predisposing characteristics of study par-
ticipants is collected at baseline only, and include health
access and insurance status, length of time in the US,
acculturation, marital status, socioeconomic status, and
personal and family history of T2DM. Measures were
primarily drawn from the Behavioral Risk Factor Sur-
veillance System (BRFSS) [35]. Information on reinfor-
cing characteristics, including self-efficacy [36], social
support and social capital [37], and religiosity are collected
at each timepoint.
Knowledge and health behaviors
At each time point, knowledge related to T2DM is assessed.
Existing measures were adapted to assess diabetes man-
agement practices [38], knowledge acquired from each
educational session, dietary practices [39], tobacco usage
[35], patterns of physical activity [40], medication adher-
ence [41], and mental health [42].
Knowledge and acceptability of CHWs
At each follow-up timepoint, we assess the mechanisms
through which CHWs operate to fulfill their role as a
bridge to the healthcare system and advocates for their
community. A measure to assess these mechanisms
included items related to trust, communal concordance,
honesty, communication, empowerment, and resource
linkages. Table 1 outlines all of the above measurement
domains & data collection timepoints in more detail.Data analyses
Analyses to compare the treatment and control group
participants are conducted at baseline to detect signifi-
cant differences. Student t-tests for normally distributed
variables (after necessary transformations) and chi-squared
tests for categorical variables were used. In the event
that randomization did not control for differences be-
tween the treatment and control groups on baseline
characteristics, we statistically controlled for those
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Descriptive statistics are conducted to characterize
study participants and to evaluate the distribution of
key exposure and outcome variables, as well as to describe
the factors that affect utilization of health care services
and the risk and protective factors for diabetes. Summary
data on medical history, length of time in the US, access
and utilization to primary health care services, and social
characteristics (e.g., marital status, employment, education)
is reported.
The primary goal of this study is to evaluate intervention
efficacy, using the generally accepted approach in evalu-
ating efficacy trials, Intention to Treat (ITT) [43]. The
analysis for each aim will be comprised of t-tests for
continuous variables and chi-square tests for categorical
variables. Indexes will be created for scale variables and
examined as continuous variables. Mann–Whitney U
Tests will be applied for indices with non-parametric
distributions.
Each aim will be tested using multivariate logistic regres-
sion analysis. The base model will consider the intervention
group as the primary predictor variable. Interaction terms
between treatment and follow-up time will be developed
to assess whether the effect of treatment varied over time.
A third set of models included other covariates identified
in the preliminary analysis as potential confounders that
may reduce the likelihood of confounding bias. Goodness-
of-fit of the final models will be assessed using the
Hosmer-Lemeshow test.
Discussion
To our knowledge, this study represents the first attempt
to document the efficacy of diabetes management strat-
egies in the NYC Bangladeshi population. Thus, the future
qualitative and quantitative findings of the submitted
protocol will fill an important gap in the health disparities
literature. Additionally, this study aims to characterize the
specific mechanisms through which CHWs operate to ful-
fill their role as a bridge between the community and the
healthcare system. This information will help to provide a
more concrete exploration of the specific characteristics of
a CHW that may be related to their efficacy in improving
health outcomes. Lastly, we anticipate that the collection
and reporting of detailed process evaluation metrics
related to both the study recruitment and implementa-
tion phases will help to inform the design of future
CHW interventions/programs.
There are several limitations to the current study. First,
blinding study staff or participants to randomization allo-
cation is not feasible, and thus may result in ascertainment
bias and subsequent threat to study validity. Additionally,
since control group participants do receive an introduc-
tory session that contains general information regarding
diabetes management, individuals may make subsequentbehavior changes leading to positive clinical outcomes that
would make observation of between-group differences
problematic. However, because the study is guided by
CPBR principles, investigators felt that the current
study design was a reasonable tradeoff between what is
scientifically rigorous and what is valuable to the com-
munity. Lastly, since many individuals reside in the
same neighborhoods in NYC, there is a potential for
contamination bias between the two arms to occur. In-
vestigators will attempt to control for this through
measuring interaction between study participants via
the survey questionnaire.
Recruitment for the study began in February 2011, and
will be conducted in phases or cohorts (rather than on an
ongoing basis). Enrollment and data collection is sched-
uled to conclude by November 2014, at which time final
data analysis will commence and study findings will be
reported in a separate publication.
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